{"id":"anti-tnf-alfa","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reaction"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Muscle pain"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL3897557","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This binding prevents TNF-alpha from interacting with its receptors on cell surfaces, thereby reducing inflammation and halting disease progression. Anti TNF Alfa is a type of biologic therapy that targets the immune system's response to inflammation.","oneSentence":"Anti TNF Alfa works by binding to and inhibiting tumor necrosis factor-alpha, a cytokine involved in systemic inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:10:21.512Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Psoriatic arthritis"},{"name":"Ankylosing spondylitis"},{"name":"Crohn's disease"},{"name":"Ulcerative colitis"}]},"trialDetails":[{"nctId":"NCT03690544","phase":"PHASE4","title":"Apremilast for RAS","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-10-12","conditions":"Recurrent Aphthous Stomatitis","enrollment":15},{"nctId":"NCT04953871","phase":"PHASE4","title":"Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis","status":"COMPLETED","sponsor":"Gunay ER","startDate":"2017-01","conditions":"Spondyloarthritis, Enthesitis, Anti-Tumor Necrosis Factor Drugs","enrollment":31},{"nctId":"NCT04226573","phase":"","title":"Effect of Preoperative Anxiety on Fetus in Pregnant Women","status":"COMPLETED","sponsor":"Bozok University","startDate":"2020-02-01","conditions":"Preoperative Anxiety, Cytokines","enrollment":30},{"nctId":"NCT03862547","phase":"NA","title":"NGF, TrKA,p75NTR in Men With ED and Diabetes With or Without MS","status":"UNKNOWN","sponsor":"University Of Perugia","startDate":"2019-01-30","conditions":"Erectile Dysfunction","enrollment":40},{"nctId":"NCT01126541","phase":"PHASE3","title":"SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2006-09","conditions":"Rheumatoid Arthritis","enrollment":224},{"nctId":"NCT01881464","phase":"","title":"Anti TNF α Improves Endothelial Dysfunction in IBD Patients","status":"UNKNOWN","sponsor":"Carmel Medical Center","startDate":"2014-05","conditions":"Crohn's Disease","enrollment":20},{"nctId":"NCT01510548","phase":"PHASE3","title":"ADALISKIAS: Adalimumab for Acute Disc Prolapse","status":"UNKNOWN","sponsor":"Kuopio University Hospital","startDate":"2007-03","conditions":"Disc Prolapse, Pain","enrollment":90},{"nctId":"NCT01237262","phase":"PHASE4","title":"Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2010-11","conditions":"Moderate to Severe Psoriasis., Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":43,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["HUMIRA-ADALIMUMAB, REMICADE-INFLIXIMAB"],"phase":"phase_2","status":"active","brandName":"Anti TNF Alfa.","genericName":"Anti TNF Alfa.","companyName":"Carmel Medical Center","companyId":"carmel-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anti TNF Alfa works by binding to and inhibiting tumor necrosis factor-alpha, a cytokine involved in systemic inflammation. Used for Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}